Impax and J&J settle Concerta patent lawsuits
2012-09-25
 

IP News

Home > IP News

Impax and J&J settle Concerta patent lawsuits

2012-09-25

Impax and J&J settle Concerta patent lawsuits


    Impax says its generic version of Concerta will go on sale in July 2013 in settlement with J&J

    NEW YORK (AP) -- Impax Laboratories Inc. said Friday its generic version of the attention deficit hyperactivity drug Concerta should go on sale in July after the company settled lawsuits with drugmaker Johnson & Johnson.

    Impax and Teva Pharmaceutical Industries Ltd. received a license to start selling their generic on July 14, 2013. Impax said U.S. sales of Concerta totaled $1.2 billion over the 12-month period ending in July. That includes the brand-name version and an authorized generic made by Watson Pharmaceuticals Inc.


Click here to read more

(Associated Press)

Privacy Statement
Our company is deeply committed to protecting the privacy and personal information of our users. In accordance with our website's privacy policy, we promise to safeguard user personal information from infringement. If you have any questions regarding our privacy policy, please feel free to contact us via email or phone. We are more than happy to assist you.